GABBR2 was found to be differentially expressed in MDS cells [61] and mutations of GABBR2 have been identified in various epilepsies, leading to neuronal hyperexcitability and seizures [102]. This evidence concerns the gene GABBR2 and myelodysplastic syndrome.